Beaglehole R.International trends in coronary heart disease mortality, morbidity and risk factors. Epidemiol Rev1990; 12: 1-15.
3.
Kaan GL, Noyez I., Vincent JG, van de Wal H., Skotnicki SH, Lacquet LKManagement of postcardiotomy cardiogenic shock with a new pulsatile ventricular assist device: Initial clinical results. ASAIO Trans1991; 37 (4): 559-63.
4.
Frazier OH, Wampler JM, Duncan WE, Dear WE, Macris M., Parnis SMFirst human use of the Hemopump, catheter-mounted ventricular assist device . Ann Thorac Surg1990; 49: 299-304.
5.
Didisheim P. , Olsen DB, Farrar DJInfections and thromboembolism with implantable cardiovascular devices. Trans ASAIO1989; 35: 54-70.
6.
Syed MFAssociation between thrombosis and infection. Trans ASAIO1993; 46: 226-30.
7.
Eberhart RCInteractions of blood and artificial surfaces. In: Arensman RM, Cornish JD eds. Extracorporeal life support. London: Blackwell, 1993: 105-25.
8.
Graham TR, Dasse K., Coumbe A.Neointimal development on textured biomaterial surfaces during clinical use of an implantable left venticular assist device. Eur J Cardiothorac Surg1990; (4): 182-90.
9.
Rosenberg G.Technological opportunities and barriers in the development of mechanical circulatory support systems. In: Hogness JR , VanAntwerp M eds. The artificial heart. Washington DC: Institute of Medicine, National Academy Press, 1991: 26-43.
10.
Cost-effectiveness analysis. In: Hogness JR, VanAntwerp M eds. The artificial heart. Washington DC: Institute of Medicine, National Academy Press, 1991:107-20.
11.
Falotico-Taylor J., McClellan M., Mosteller F.The use of quality of life measures in technology assessment. In: Mosteller F, Falotico-Taylor J eds. Quality of life and technology assessment. Washington DC: Institute of Medicine, National Academy Press, 1989: 7-44.
12.
Loisance D. , Deleuze PH, Mazzucotelli JP, Abe Y., LeBesnaris P., Dubois-Rande JLInitial experience with the wearable Novacor ventricular assist system. J Thorac Cardiovasc Surg1994; 108: 176-95.
13.
Levin HR, Chen JM, Oz MC et al. Potential of left ventricular assist devices as outpatient therapy while awaiting transplantation. Ann Thorac Surg1994; 58: 1515-20.
14.
The registry of the International Society for Heart and Lung Transplantation: Ninth Official Report, 1992; J Heart Lung Transplant1992; 11 (4): 599-606.
15.
Report on the Working Party on the Supply of Donor Organs for Transplantation (Chairman: Sir Raymond Hoffenberg). London: HMSO, 1987.
16.
Bach FHXenotransplantation: A view to the future. Transplant Proc1993; 25: 25-29.
17.
Oakley RM, Jarvis JCCardiomyoplasty: A critical review of experimental and clinical results. Circulation1994; 90 (4): 2085-90.
18.
Salmons S., Jarvis JCThe working capacity of skeletal muscle transformed for use in a cardiac assist role. In: Chiu RCJ, Bourgeois IM eds. Transformed muscle for cardiac assist and repair. Bakken Research Series, Volume 2. Mt Kisko, NY: Futura Publishing , 1990: 89-104.
19.
Nakajima H. , Thomas GA, Hammond RL et al. Chronic morphological changes of skeletal ventricles in circulation. Ann Thorac Surg1994; 57: 912-20.
20.
Farrar D., Hill JDA new skeletal muscle linear pull energy converter as a power source for prosthetic circulatory support devices. J Heart Lung Transplant1992 ; 11: S341-50.